# The COCOA-PAD II Trial

Study · id `cardio:ct-nct04794530` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT04794530](<https://clinicaltrials.gov/study/NCT04794530>), retrieved 31 October 2026. No person wrote or checked this page.

Also called: NCT04794530

Browse, organ or system: Blood vessels  
Browse, condition area: Coronary and vascular disease  

## In plain language

A phase 3 trial registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 190 participants.

## Technical summary

Registry record NCT04794530. Randomized; quadruple masking; primary purpose treatment. Start 2021-11-19 (actual); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase: Phase 3
- Enrolled: 190 participants (planned count; ClinicalTrials.gov record NCT04794530, source copy `cardio:ctgov-nct04794530-2026-05-28`, retrieved 2026-10-31)
- Started: 2021-11-19 (actual) (ClinicalTrials.gov record NCT04794530, source copy `cardio:ctgov-nct04794530-2026-05-28`, retrieved 2026-10-31)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT04794530, source copy `cardio:ctgov-nct04794530-2026-05-28`, retrieved 2026-10-31)
- Completion: 2027-06-01 (anticipated) (ClinicalTrials.gov record NCT04794530, source copy `cardio:ctgov-nct04794530-2026-05-28`, retrieved 2026-10-31)
- Countries: United States (ClinicalTrials.gov record NCT04794530, source copy `cardio:ctgov-nct04794530-2026-05-28`, retrieved 2026-10-31)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct04794530-2026-05-28`, retrieved 2026-10-31)

## The registry's words

- Brief title: The COCOA-PAD II Trial
- Acronym: COCOA-PAD II
- Condition: Peripheral Artery Disease
- Intervention (Drug): cocoa flavanols
- Intervention (Drug): placebo
- Lead sponsor: Northwestern University
- Lead sponsor class: OTHER
- Collaborator: National Institute on Aging (NIA)
- Collaborator class: NIH
- Collaborator: University of Minnesota
- Collaborator class: OTHER
- Collaborator: University of Chicago
- Collaborator class: OTHER

## Connected pages

- Registry condition terms include this condition: Peripheral artery disease (`cardio:peripheral-artery-disease`)
- Registry lists this organization as the lead sponsor: Northwestern University (`cardio:org-northwestern-university`)
- Registry lists this organization as a collaborator: National Institute on Aging (`cardio:nia`)
- Registry lists this organization as a collaborator: University of Minnesota (`cardio:org-university-of-minnesota`)
- Registry lists this organization as a collaborator: University of Chicago (`cardio:org-university-of-chicago`)

## Provenance

Content hash: a0e5a8a9525247ba44c7f94c65ce25f36f057955f7c5d67b3e7d4194e35161c7
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
